The backstory: CVS Caremark, the nations largest pharmacy benefit manager, stopped covering Zepbound on July 1, 2025, after reaching a deal with Novo Nordisk, the maker of rival GLP-1 drug Wegovy
Why Choose Klinic in Dallas for Weight Loss Navigating insurance and authorization can hinder starting a weight loss journey
Hair loss associated with GLP-1 medications appears to be related to rapid weight loss rather than the medications themselves
Clinical Use: Tirzepatide is FDA approved for treating type 2 diabetes and promoting weight loss
The body produces it in bursts after meals, and it is quickly degraded
The second piece, which scientists are still in the process of investigating, is how these drugs affect thought processes